Prognostic criteria in Clostridium difficile colitis

American Journal of Gastroenterology

Volumn 91, Issue 3, 1996, Pages 460-464

  Ramaswamy, Ravi ^b   Grover, Harish ^b   Corpuz, Marilou ^b   Daniels, Peter ^b   Pitchumoni, C S ^a  

^a OUR LADY OF MERCY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CANCER CHEMOTHERAPY; CLOSTRIDIUM DIFFICILE; COLITIS; COLON FLORA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SEX FACTORS;

EID: 0029863854     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bartlett JG, Chang TW, Gurwith M, et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978;298:531-4.
2. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992;15: 573-81.
3. Bartlett JG. Clostridium difficile: Clinical considerations. Rev Infect Dis 1990;12(Suppl 2):243-51.
4. Tedesco FJ, Barton RW, Alpers DH. Clindamycin-associated colitis. Ann Intern Med 1974;81:429-33.
5. Mogg GAG, Keighley MRB, Burdon DW. Antibiotic-associated colitis: A review of 66 cases. Br J Surg 1979;66:738-42.
6. Morus JB, Zollinger RM, Stellato TA. Role of surgery in antibiotic-induced pseudomembranous enterocolitis. Am J Surg 1990;160: 535-9.
7. Thibault A, Miller MA, Gaese C. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol 1991;12:345-8.
8. Brown E, Talbot GH, Axelrod P, et al. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 1990;11:283-90.
9. Samore MH, DeGirolami PC, Tlucko A, et al. Clostridium difficile colonization and diarrhea in a tertiary care hospital. Clin Infect Dis 1994;18:181-7.
10. Aronsson B, Mollby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: Epidemiological data from Sweden, 1980-1982. J Infect Dis 1985;151:3:476-81.
11. Mcfarland L. Clostridium difficile-associated disease. In: Surawicz C, Owen RL, eds. Gastrointestinal and hepatic infections. Philadelphia: WB Saunders, 1995: 153-75.
12. McEllistrum MC, Collins JC, Powers JS. Admission serum albumin level as a predictor of outcome among geriatric patients. South Med J 1993;86(12):1360-1.
13. Aptaker RL, Roth EJ, Reichart G, et al. Serum albumin level as a predictor of geriatric stroke rehabilitation outcome. Arch Phys Med Rehabil 1994;75(1):80-4.
14. Rybolt AH, Bennet RG, Laughon BE. Protein losing anteropathy associated with Clostridium difficile infection. Lancet 1989;1: 1353-5.
15. McFarland LV, Mulligan ME, Kwok RY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
16. Olson MM, Shanholtzer CJ, Lee JT, et al. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center. Infect Control Hosp Epidemiol 1994;15:371-81.
17. Gerding DW, Olson MM, Peterson CR. Clostridium difficile-associated diarrhea and colitis in adults. Arch Intern Med 1986;146: 95-100.
18. Mulligan ME. Epidemiology of Clostridium difficile-induced intestinal disease. Rev Infect Dis 1984;6:S222-8.